Skip to content

Clinical trials

Phase 1 Carcinoma, Hepatocellular trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1 Country / region: China Clear all

110 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20111
20122
20131
20142
20154
20161
20178
20185
201910
202010
20219
202210
20237
202412
202514
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status45
Recruiting32
Completed16
Not yet recruiting9
Active, not recruiting2
Suspended2
Terminated2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Ditan Hospital5
West China Hospital5
Zhejiang University4
Beijing 302 Hospital3
Beijing Tsinghua Chang Gung Hospital3
Eastern Hepatobiliary Surgery Hospital3
Fudan University3
Lion TCR Pte. Ltd.3
Peking Union Medical College Hospital3
Beijing Gene Key Life Technology Co., Ltd2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular110
Liver Neoplasms12
Carcinoma, Non-Small-Cell Lung9
Colorectal Neoplasms7
Stomach Neoplasms6
Lung Neoplasms5
Cholangiocarcinoma4
Colonic Neoplasms4
Ovarian Neoplasms4
Squamous Cell Carcinoma of Head and Neck4

Trials

Showing 1 to 25 of 110. Each trial links to its page on Pharma Observatory.

10 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.